25 XP   0   0   10

Zhejiang Dayang Biotech Group Co
Buy, Hold or Sell?

Let's analyse Zhejiang Dayang Biotech Group Co together

PenkeI guess you are interested in Zhejiang Dayang Biotech Group Co. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Dayang Biotech Group Co. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Dayang Biotech Group Co

I send you an email if I find something interesting about Zhejiang Dayang Biotech Group Co.

Quick analysis of Zhejiang Dayang Biotech Group Co (30 sec.)










What can you expect buying and holding a share of Zhejiang Dayang Biotech Group Co? (30 sec.)

How much money do you get?

How much money do you get?
¥0.26
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥11.73
Expected worth in 1 year
¥11.46
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥1.59
Return On Investment
9.6%

For what price can you sell your share?

Current Price per Share
¥16.65
Expected price per share
¥11.91 - ¥19.55
How sure are you?
50%

1. Valuation of Zhejiang Dayang Biotech Group Co (5 min.)




Live pricePrice per Share (EOD)

¥16.65

Intrinsic Value Per Share

¥-13.88 - ¥-5.89

Total Value Per Share

¥-2.15 - ¥5.84

2. Growth of Zhejiang Dayang Biotech Group Co (5 min.)




Is Zhejiang Dayang Biotech Group Co growing?

Current yearPrevious yearGrowGrow %
How rich?$136m$136.8m-$781.6k-0.6%

How much money is Zhejiang Dayang Biotech Group Co making?

Current yearPrevious yearGrowGrow %
Making money$11.1m$9.6m$1.4m13.3%
Net Profit Margin7.6%8.9%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Dayang Biotech Group Co (5 min.)




4. Comparing to competitors in the Chemicals industry (5 min.)




  Industry Rankings (Chemicals)  


Richest
#233 / 310

Most Revenue
#199 / 310

Most Profit
#147 / 310

Most Efficient
#122 / 310

What can you expect buying and holding a share of Zhejiang Dayang Biotech Group Co? (5 min.)

Welcome investor! Zhejiang Dayang Biotech Group Co's management wants to use your money to grow the business. In return you get a share of Zhejiang Dayang Biotech Group Co.

What can you expect buying and holding a share of Zhejiang Dayang Biotech Group Co?

First you should know what it really means to hold a share of Zhejiang Dayang Biotech Group Co. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Dayang Biotech Group Co is ¥16.65. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Dayang Biotech Group Co.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Dayang Biotech Group Co, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥11.73. Based on the TTM, the Book Value Change Per Share is ¥-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.39 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.46 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Dayang Biotech Group Co.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.130.8%0.130.8%0.120.7%0.130.8%0.110.7%
Usd Book Value Change Per Share-0.01-0.1%-0.01-0.1%0.050.3%0.211.3%0.231.4%
Usd Dividend Per Share0.060.4%0.060.4%0.060.4%0.050.3%0.040.3%
Usd Total Gains Per Share0.050.3%0.050.3%0.120.7%0.261.6%0.281.7%
Usd Price Per Share3.83-3.83-5.77-3.35-2.39-
Price to Earnings Ratio28.83-28.83-50.15-25.29-18.06-
Price-to-Total Gains Ratio69.69-69.69-49.53-42.80-42.80-
Price to Book Ratio2.36-2.36-3.54-2.09-1.49-
Price-to-Total Gains Ratio69.69-69.69-49.53-42.80-42.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.299365
Number of shares434
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.060.05
Usd Book Value Change Per Share-0.010.21
Usd Total Gains Per Share0.050.26
Gains per Quarter (434 shares)23.83112.18
Gains per Year (434 shares)95.32448.74
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1111-168579370439
2223-32180158739888
3334-4827523811091337
4446-6537031714781786
5557-8146539618482235
6669-9756047522172684
7780-11365555525873133
8892-12975063429563582
91003-14584571333264031
101115-16294079236954480

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%6.01.00.085.7%6.01.00.085.7%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%

Fundamentals of Zhejiang Dayang Biotech Group Co

About Zhejiang Dayang Biotech Group Co

Zhe Jiang Dayang Biotech Group Co., Ltd. operates as a chemical raw material manufacturing company in China and internationally. The company offers inorganic chemicals, including food additive potassium carbonate, potassium carbonate, food additive potassium bicarbonate, potassium bicarbonate, food and feed potassium chloride, agricultural grade ammonium chloride, and industrial grade ammonium chloride. It also offers fine chemical products, such as 2-chloro-6-fiuorobenzaldehyde, 2-chloro-6-fluorobenzyl chloride, and anisole products; veterinary APIs, including amprolium HCL; and veterinary drug premixes comprising anisole and enramycin premixes. The company was founded in 1976 and is based in Jiande, China.

Fundamental data was last updated by Penke on 2024-04-23 06:42:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Zhejiang Dayang Biotech Group Co.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Dayang Biotech Group Co earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Dayang Biotech Group Co to the Chemicals industry mean.
  • A Net Profit Margin of 7.6% means that ¥0.08 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Dayang Biotech Group Co:

  • The MRQ is 7.6%. The company is making a profit. +1
  • The TTM is 7.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ7.6%TTM7.6%0.0%
TTM7.6%YOY8.9%-1.3%
TTM7.6%5Y11.0%-3.4%
5Y11.0%10Y10.1%+0.9%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ7.6%3.8%+3.8%
TTM7.6%4.4%+3.2%
YOY8.9%7.0%+1.9%
5Y11.0%5.4%+5.6%
10Y10.1%5.6%+4.5%
1.1.2. Return on Assets

Shows how efficient Zhejiang Dayang Biotech Group Co is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Dayang Biotech Group Co to the Chemicals industry mean.
  • 5.4% Return on Assets means that Zhejiang Dayang Biotech Group Co generated ¥0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Dayang Biotech Group Co:

  • The MRQ is 5.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.4%TTM5.4%0.0%
TTM5.4%YOY5.1%+0.3%
TTM5.4%5Y8.4%-3.0%
5Y8.4%10Y8.3%+0.1%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4%1.3%+4.1%
TTM5.4%1.5%+3.9%
YOY5.1%2.7%+2.4%
5Y8.4%2.0%+6.4%
10Y8.3%2.0%+6.3%
1.1.3. Return on Equity

Shows how efficient Zhejiang Dayang Biotech Group Co is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Dayang Biotech Group Co to the Chemicals industry mean.
  • 8.2% Return on Equity means Zhejiang Dayang Biotech Group Co generated ¥0.08 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Dayang Biotech Group Co:

  • The MRQ is 8.2%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 8.2%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ8.2%TTM8.2%0.0%
TTM8.2%YOY7.1%+1.1%
TTM8.2%5Y11.4%-3.2%
5Y11.4%10Y12.0%-0.7%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ8.2%2.4%+5.8%
TTM8.2%2.8%+5.4%
YOY7.1%5.2%+1.9%
5Y11.4%3.3%+8.1%
10Y12.0%3.5%+8.5%

1.2. Operating Efficiency of Zhejiang Dayang Biotech Group Co.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Dayang Biotech Group Co is operating .

  • Measures how much profit Zhejiang Dayang Biotech Group Co makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Dayang Biotech Group Co to the Chemicals industry mean.
  • An Operating Margin of 4.8% means the company generated ¥0.05  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Dayang Biotech Group Co:

  • The MRQ is 4.8%. The company is operating less efficient.
  • The TTM is 4.8%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ4.8%TTM4.8%0.0%
TTM4.8%YOY8.5%-3.7%
TTM4.8%5Y10.9%-6.1%
5Y10.9%10Y11.5%-0.6%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8%6.7%-1.9%
TTM4.8%4.1%+0.7%
YOY8.5%9.2%-0.7%
5Y10.9%7.4%+3.5%
10Y11.5%6.8%+4.7%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Dayang Biotech Group Co is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Chemicals industry mean).
  • An Operation Ratio of 1.81 means that the operating costs are ¥1.81 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Dayang Biotech Group Co:

  • The MRQ is 1.808. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.808. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.808TTM1.8080.000
TTM1.808YOY1.712+0.096
TTM1.8085Y1.666+0.142
5Y1.66610Y1.665+0.001
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8081.695+0.113
TTM1.8081.684+0.124
YOY1.7121.590+0.122
5Y1.6661.626+0.040
10Y1.6651.408+0.257

1.3. Liquidity of Zhejiang Dayang Biotech Group Co.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Dayang Biotech Group Co is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Chemicals industry mean).
  • A Current Ratio of 1.52 means the company has ¥1.52 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Dayang Biotech Group Co:

  • The MRQ is 1.523. The company is able to pay all its short-term debts. +1
  • The TTM is 1.523. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.523TTM1.5230.000
TTM1.523YOY2.342-0.819
TTM1.5235Y2.244-0.721
5Y2.24410Y1.920+0.324
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5231.606-0.083
TTM1.5231.630-0.107
YOY2.3421.687+0.655
5Y2.2441.772+0.472
10Y1.9201.560+0.360
1.3.2. Quick Ratio

Measures if Zhejiang Dayang Biotech Group Co is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Dayang Biotech Group Co to the Chemicals industry mean.
  • A Quick Ratio of 0.76 means the company can pay off ¥0.76 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Dayang Biotech Group Co:

  • The MRQ is 0.764. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.764. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.764TTM0.7640.000
TTM0.764YOY0.990-0.226
TTM0.7645Y1.126-0.362
5Y1.12610Y0.941+0.185
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7640.537+0.227
TTM0.7640.572+0.192
YOY0.9900.720+0.270
5Y1.1260.731+0.395
10Y0.9410.739+0.202

1.4. Solvency of Zhejiang Dayang Biotech Group Co.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Dayang Biotech Group Co assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Dayang Biotech Group Co to Chemicals industry mean.
  • A Debt to Asset Ratio of 0.35 means that Zhejiang Dayang Biotech Group Co assets are financed with 34.7% credit (debt) and the remaining percentage (100% - 34.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Dayang Biotech Group Co:

  • The MRQ is 0.347. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.347. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.347TTM0.3470.000
TTM0.347YOY0.279+0.068
TTM0.3475Y0.268+0.078
5Y0.26810Y0.313-0.045
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3470.416-0.069
TTM0.3470.416-0.069
YOY0.2790.425-0.146
5Y0.2680.413-0.145
10Y0.3130.420-0.107
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Dayang Biotech Group Co is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Dayang Biotech Group Co to the Chemicals industry mean.
  • A Debt to Equity ratio of 53.1% means that company has ¥0.53 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Dayang Biotech Group Co:

  • The MRQ is 0.531. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.531. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.531TTM0.5310.000
TTM0.531YOY0.387+0.144
TTM0.5315Y0.372+0.158
5Y0.37210Y0.488-0.116
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5310.763-0.232
TTM0.5310.753-0.222
YOY0.3870.759-0.372
5Y0.3720.772-0.400
10Y0.4880.808-0.320

2. Market Valuation of Zhejiang Dayang Biotech Group Co

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Dayang Biotech Group Co generates.

  • Above 15 is considered overpriced but always compare Zhejiang Dayang Biotech Group Co to the Chemicals industry mean.
  • A PE ratio of 28.83 means the investor is paying ¥28.83 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Dayang Biotech Group Co:

  • The EOD is 17.325. Based on the earnings, the company is fair priced.
  • The MRQ is 28.834. Based on the earnings, the company is overpriced. -1
  • The TTM is 28.834. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD17.325MRQ28.834-11.509
MRQ28.834TTM28.8340.000
TTM28.834YOY50.153-21.320
TTM28.8345Y25.288+3.546
5Y25.28810Y18.063+7.225
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD17.3258.236+9.089
MRQ28.8349.695+19.139
TTM28.83411.300+17.534
YOY50.15312.517+37.636
5Y25.28816.791+8.497
10Y18.06323.783-5.720
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Dayang Biotech Group Co:

  • The EOD is -109.570. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -182.353. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -182.353. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-109.570MRQ-182.353+72.784
MRQ-182.353TTM-182.3530.000
TTM-182.353YOY-27.306-155.048
TTM-182.3535Y-112.431-69.922
5Y-112.43110Y-80.308-32.123
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD-109.5703.169-112.739
MRQ-182.3533.444-185.797
TTM-182.3530.598-182.951
YOY-27.3063.451-30.757
5Y-112.4312.591-115.022
10Y-80.3082.004-82.312
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Dayang Biotech Group Co is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Chemicals industry mean).
  • A PB ratio of 2.36 means the investor is paying ¥2.36 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Dayang Biotech Group Co:

  • The EOD is 1.420. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.363. Based on the equity, the company is underpriced. +1
  • The TTM is 2.363. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.420MRQ2.363-0.943
MRQ2.363TTM2.3630.000
TTM2.363YOY3.544-1.181
TTM2.3635Y2.089+0.274
5Y2.08910Y1.492+0.597
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD1.4201.325+0.095
MRQ2.3631.524+0.839
TTM2.3631.547+0.816
YOY3.5441.947+1.597
5Y2.0891.750+0.339
10Y1.4922.036-0.544
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Dayang Biotech Group Co compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.067-0.0670%0.388-117%1.541-104%1.675-104%
Book Value Per Share--11.72711.7270%11.794-1%9.220+27%7.550+55%
Current Ratio--1.5231.5230%2.342-35%2.244-32%1.920-21%
Debt To Asset Ratio--0.3470.3470%0.279+24%0.268+29%0.313+11%
Debt To Equity Ratio--0.5310.5310%0.387+37%0.372+43%0.488+9%
Dividend Per Share--0.4650.4650%0.456+2%0.330+41%0.321+45%
Eps--0.9610.9610%0.833+15%0.935+3%0.802+20%
Free Cash Flow Per Share---0.152-0.1520%-1.531+907%-0.256+69%-0.089-42%
Free Cash Flow To Equity Per Share---0.152-0.1520%-0.467+207%0.778-120%0.581-126%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---5.889--------
Intrinsic Value_10Y_min---13.878--------
Intrinsic Value_1Y_max---0.329--------
Intrinsic Value_1Y_min---0.815--------
Intrinsic Value_3Y_max---1.188--------
Intrinsic Value_3Y_min---2.962--------
Intrinsic Value_5Y_max---2.286--------
Intrinsic Value_5Y_min---5.655--------
Market Cap1398600000.000-66%2327648400.0002327648400.0000%3511191600.000-34%2037168000.000+14%1455120000.000+60%
Net Profit Margin--0.0760.0760%0.089-15%0.110-31%0.101-24%
Operating Margin--0.0480.0480%0.085-44%0.109-56%0.115-59%
Operating Ratio--1.8081.8080%1.712+6%1.666+9%1.665+9%
Pb Ratio1.420-66%2.3632.3630%3.544-33%2.089+13%1.492+58%
Pe Ratio17.325-66%28.83428.8340%50.153-43%25.288+14%18.063+60%
Price Per Share16.650-66%27.71027.7100%41.800-34%24.252+14%17.323+60%
Price To Free Cash Flow Ratio-109.570+40%-182.353-182.3530%-27.306-85%-112.431-38%-80.308-56%
Price To Total Gains Ratio41.875-66%69.69269.6920%49.534+41%42.798+63%42.798+63%
Quick Ratio--0.7640.7640%0.990-23%1.126-32%0.941-19%
Return On Assets--0.0540.0540%0.051+5%0.084-36%0.083-35%
Return On Equity--0.0820.0820%0.071+16%0.114-28%0.120-32%
Total Gains Per Share--0.3980.3980%0.844-53%1.872-79%1.996-80%
Usd Book Value--136035326.005136035326.0050%136816965.943-1%106960992.544+27%87588047.752+55%
Usd Book Value Change Per Share---0.009-0.0090%0.054-117%0.213-104%0.231-104%
Usd Book Value Per Share--1.6191.6190%1.629-1%1.273+27%1.043+55%
Usd Dividend Per Share--0.0640.0640%0.063+2%0.046+41%0.044+45%
Usd Eps--0.1330.1330%0.115+15%0.129+3%0.111+20%
Usd Free Cash Flow---1762777.105-1762777.1050%-17758140.187+907%-2975036.327+69%-1028226.193-42%
Usd Free Cash Flow Per Share---0.021-0.0210%-0.211+907%-0.035+69%-0.012-42%
Usd Free Cash Flow To Equity Per Share---0.021-0.0210%-0.064+207%0.108-120%0.080-126%
Usd Market Cap193146660.000-66%321448244.040321448244.0400%484895559.960-34%281332900.800+14%200952072.000+60%
Usd Price Per Share2.299-66%3.8273.8270%5.773-34%3.349+14%2.392+60%
Usd Profit--11148391.64311148391.6430%9668287.586+15%10844608.675+3%9306123.227+20%
Usd Revenue--146124292.873146124292.8730%108161201.285+35%102899944.709+42%93148708.918+57%
Usd Total Gains Per Share--0.0550.0550%0.117-53%0.258-79%0.276-80%
 EOD+3 -5MRQTTM+0 -0YOY+18 -175Y+17 -1810Y+14 -21

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Dayang Biotech Group Co based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1517.325
Price to Book Ratio (EOD)Between0-11.420
Net Profit Margin (MRQ)Greater than00.076
Operating Margin (MRQ)Greater than00.048
Quick Ratio (MRQ)Greater than10.764
Current Ratio (MRQ)Greater than11.523
Debt to Asset Ratio (MRQ)Less than10.347
Debt to Equity Ratio (MRQ)Less than10.531
Return on Equity (MRQ)Greater than0.150.082
Return on Assets (MRQ)Greater than0.050.054
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Dayang Biotech Group Co based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.010
Ma 20Greater thanMa 5018.042
Ma 50Greater thanMa 10017.557
Ma 100Greater thanMa 20020.091
OpenGreater thanClose16.390
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Tax Provision  4,3542,8777,2311,4238,654-2,5256,129-29,401-23,272



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,507,974
Total Liabilities522,924
Total Stockholder Equity985,049
 As reported
Total Liabilities 522,924
Total Stockholder Equity+ 985,049
Total Assets = 1,507,974

Assets

Total Assets1,507,974
Total Current Assets728,163
Long-term Assets779,811
Total Current Assets
Cash And Cash Equivalents 131,111
Short-term Investments 296,478
Net Receivables 68,991
Inventory 126,871
Other Current Assets 24,937
Total Current Assets  (as reported)728,163
Total Current Assets  (calculated)648,388
+/- 79,775
Long-term Assets
Property Plant Equipment 616,167
Intangible Assets 95,364
Long-term Assets Other 20,052
Long-term Assets  (as reported)779,811
Long-term Assets  (calculated)731,583
+/- 48,228

Liabilities & Shareholders' Equity

Total Current Liabilities478,239
Long-term Liabilities44,686
Total Stockholder Equity985,049
Total Current Liabilities
Short Long Term Debt 252,114
Accounts payable 125,774
Other Current Liabilities 41,572
Total Current Liabilities  (as reported)478,239
Total Current Liabilities  (calculated)419,460
+/- 58,778
Long-term Liabilities
Long-term Liabilities  (as reported)44,686
Long-term Liabilities  (calculated)0
+/- 44,686
Total Stockholder Equity
Retained Earnings 413,116
Other Stockholders Equity 162
Total Stockholder Equity (as reported)985,049
Total Stockholder Equity (calculated)413,279
+/- 571,771
Other
Capital Stock60,000
Common Stock Shares Outstanding 60,000
Net Debt 121,003
Net Invested Capital 1,237,164
Net Tangible Assets 889,685
Net Working Capital 249,924
Property Plant and Equipment Gross 893,092



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
466,716
513,079
601,605
645,600
1,228,801
1,374,347
1,507,974
1,507,9741,374,3471,228,801645,600601,605513,079466,716
   > Total Current Assets 
193,872
223,792
269,915
265,593
698,290
742,699
728,163
728,163742,699698,290265,593269,915223,792193,872
       Cash And Cash Equivalents 
35,996
41,211
30,276
53,120
69,360
131,883
131,111
131,111131,88369,36053,12030,27641,21135,996
       Short-term Investments 
0
0
0
0
370,082
279,765
296,478
296,478279,765370,0820000
       Net Receivables 
77,172
101,267
139,549
121,270
30,629
34,264
68,991
68,99134,26430,629121,270139,549101,26777,172
       Inventory 
43,793
57,208
81,310
82,390
69,836
161,608
126,871
126,871161,60869,83682,39081,31057,20843,793
       Other Current Assets 
25,337
12,107
18,454
8,404
24,618
16,300
24,937
24,93716,30024,6188,40418,45412,10725,337
   > Long-term Assets 
272,844
289,287
331,690
380,007
530,511
631,648
779,811
779,811631,648530,511380,007331,690289,287272,844
       Property Plant Equipment 
198,553
221,806
247,653
274,170
433,570
528,022
616,167
616,167528,022433,570274,170247,653221,806198,553
       Intangible Assets 
34,633
38,467
57,728
58,166
57,480
56,729
95,364
95,36456,72957,48058,16657,72838,46734,633
       Other Assets 
32,850
26,007
23,760
45,216
37,551
44,379
0
044,37937,55145,21623,76026,00732,850
> Total Liabilities 
237,367
175,365
160,989
147,514
270,671
383,637
522,924
522,924383,637270,671147,514160,989175,365237,367
   > Total Current Liabilities 
227,055
163,880
146,770
130,641
200,515
317,165
478,239
478,239317,165200,515130,641146,770163,880227,055
       Short Long Term Debt 
147,000
75,000
23,000
23,000
0
139,071
252,114
252,114139,071023,00023,00075,000147,000
       Accounts payable 
54,623
47,697
69,962
80,330
168,475
149,159
125,774
125,774149,159168,47580,33069,96247,69754,623
       Other Current Liabilities 
20,554
24,864
35,706
12,165
22,966
17,584
41,572
41,57217,58422,96612,16535,70624,86420,554
   > Long-term Liabilities 
10,312
11,485
14,219
16,873
70,156
66,473
44,686
44,68666,47370,15616,87314,21911,48510,312
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
1,702
868
0
08681,7020000
       Other Liabilities 
10,312
11,485
14,219
16,873
20,289
25,805
0
025,80520,28916,87314,21911,48510,312
> Total Stockholder Equity
229,238
337,714
440,617
498,086
958,130
990,709
985,049
985,049990,709958,130498,086440,617337,714229,238
   Common Stock
35,000
41,500
45,000
45,000
60,000
60,000
0
060,00060,00045,00045,00041,50035,000
   Retained Earnings 
120,119
147,550
197,597
254,594
332,700
366,709
413,116
413,116366,709332,700254,594197,597147,550120,119
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 
0
794
1,726
2,198
1,439
9
162
16291,4392,1981,7267940



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,037,673
Cost of Revenue-877,495
Gross Profit160,178160,178
 
Operating Income (+$)
Gross Profit160,178
Operating Expense-986,718
Operating Income50,955-826,540
 
Operating Expense (+$)
Research Development38,643
Selling General Administrative36,405
Selling And Marketing Expenses-
Operating Expense986,71875,048
 
Net Interest Income (+$)
Interest Income2,589
Interest Expense-3,504
Other Finance Cost-1,335
Net Interest Income-2,250
 
Pretax Income (+$)
Operating Income50,955
Net Interest Income-2,250
Other Non-Operating Income Expenses-
Income Before Tax (EBT)52,34150,955
EBIT - interestExpense = -3,504
70,802
74,306
Interest Expense3,504
Earnings Before Interest and Taxes (EBIT)-55,845
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax52,341
Tax Provision--18,461
Net Income From Continuing Ops70,80270,802
Net Income70,802
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-2,250
 

Technical Analysis of Zhejiang Dayang Biotech Group Co
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Dayang Biotech Group Co. The general trend of Zhejiang Dayang Biotech Group Co is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Dayang Biotech Group Co's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Dayang Biotech Group Co.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 17.04 < 17.42 < 19.55.

The bearish price targets are: 15.26 > 11.91.

Tweet this
Zhejiang Dayang Biotech Group Co Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Dayang Biotech Group Co. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Dayang Biotech Group Co Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Dayang Biotech Group Co. The current macd is -0.56193512.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zhejiang Dayang Biotech Group Co price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Zhejiang Dayang Biotech Group Co. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Zhejiang Dayang Biotech Group Co price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Zhejiang Dayang Biotech Group Co Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Dayang Biotech Group Co Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Dayang Biotech Group Co. The current adx is 31.67.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Zhejiang Dayang Biotech Group Co shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Zhejiang Dayang Biotech Group Co Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Dayang Biotech Group Co. The current sar is 18.90.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Zhejiang Dayang Biotech Group Co Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Dayang Biotech Group Co. The current rsi is 42.01. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Zhejiang Dayang Biotech Group Co Daily Relative Strength Index (RSI) ChartZhejiang Dayang Biotech Group Co Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Dayang Biotech Group Co. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Dayang Biotech Group Co price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Zhejiang Dayang Biotech Group Co Daily Stochastic Oscillator ChartZhejiang Dayang Biotech Group Co Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Dayang Biotech Group Co. The current cci is -90.18349379.

Zhejiang Dayang Biotech Group Co Daily Commodity Channel Index (CCI) ChartZhejiang Dayang Biotech Group Co Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Dayang Biotech Group Co. The current cmo is -18.22084163.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Zhejiang Dayang Biotech Group Co Daily Chande Momentum Oscillator (CMO) ChartZhejiang Dayang Biotech Group Co Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Dayang Biotech Group Co. The current willr is -69.31567329.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Zhejiang Dayang Biotech Group Co is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Zhejiang Dayang Biotech Group Co Daily Williams %R ChartZhejiang Dayang Biotech Group Co Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Dayang Biotech Group Co.

Zhejiang Dayang Biotech Group Co Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Dayang Biotech Group Co. The current atr is 0.93749278.

Zhejiang Dayang Biotech Group Co Daily Average True Range (ATR) ChartZhejiang Dayang Biotech Group Co Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Dayang Biotech Group Co. The current obv is 38,916,243.

Zhejiang Dayang Biotech Group Co Daily On-Balance Volume (OBV) ChartZhejiang Dayang Biotech Group Co Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Dayang Biotech Group Co. The current mfi is 52.50.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Zhejiang Dayang Biotech Group Co Daily Money Flow Index (MFI) ChartZhejiang Dayang Biotech Group Co Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Dayang Biotech Group Co.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-25STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Zhejiang Dayang Biotech Group Co Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Dayang Biotech Group Co based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.010
Ma 20Greater thanMa 5018.042
Ma 50Greater thanMa 10017.557
Ma 100Greater thanMa 20020.091
OpenGreater thanClose16.390
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Dayang Biotech Group Co with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Dayang Biotech Group Co? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Dayang Biotech Group Co? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Dayang Biotech Group Co

I send you an email if I find something interesting about Zhejiang Dayang Biotech Group Co.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Dayang Biotech Group Co.

Receive notifications about Zhejiang Dayang Biotech Group Co in your mailbox!